ATROVENT 20 micrograms/dose, solution for inhalation in a pressurised container 200 doses
Active ingredients: Anhydrous ipratropium bromide, Ipratropium bromide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation200 dosesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATROVENT 20 microgrammes/dose, solution pour inhalation en flacon pressurisé
- Pharmaceutical form
- solution pour inhalation
- Route of administration
- inhalée
- Presentation description
- 1 flacon(s) pressurisé(s) acier de 200 doses avec valve(s) avec embout(s) buccal(aux)
- Marketing authorisation holder
- BOEHRINGER INGELHEIM FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 8 Oct 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66698997CIP73607978CIP133400936079786Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IPRATROPIUM (BROMURE D') MONOHYDRATÉsolution | — | SA |
| IPRATROPIUM (BROMURE D') ANHYDREsolution | 20 microgrammes · une dose | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.